Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
Officials investigate brain tumor that killed 3 children in Ocean Springs
Wed, 13 Dec 2017 15:50:00 GMT (Jackson Clarion Ledger)
Officials Investigate Brain Tumor That Killed 3 Children | Mississippi ...
Tue, 12 Dec 2017 20:36:32 GMT (U.S. News & World Report)
Friday event on the Square to support Ewing child with rare brain tumor
Thu, 14 Dec 2017 06:06:41 GMT (Du Quoin Evening Call)
Community rallies around young father as he battles another brain tumor
Thu, 14 Dec 2017 02:28:00 GMT (KHQ Right Now)
Chicago Bears surprise teen brain tumor survivor
Tue, 12 Dec 2017 16:12:26 GMT (WABC)
Boy battling brain tumor gets special tour of John Deere factory
Mon, 11 Dec 2017 16:27:57 GMT (Fox News)
Community brings Halloween to Saginaw girl with brain tumor
Mon, 11 Dec 2017 10:58:17 GMT (WNEM Saginaw)
Protein injected into brain tumor showing results
Sat, 09 Dec 2017 02:19:34 GMT (KFSN)
Local teenager suffers from brain tumor, but gives back
Wed, 06 Dec 2017 22:11:48 GMT (Local 8 Now)
New weakness found in most common childhood malignant brain tumor
Wed, 06 Dec 2017 15:56:49 GMT (Science Daily)
12/14/2017 8:40:24 AM
Feed cached:12/14/2017 8:54:36 AM

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
  
 
Dani Saleh Brain Cancer Research Fund at UCLA


The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.



Persistent diffusion-restricted lesions in bevacizumab-treated malignant gliomas are associated with improved survival compared with matched controls.
AJNR Am J Neuroradiol


Relationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastoma.
AJNR Am J Neuroradiol


Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapies.
Neuropathol Appl Neurobiol


Differential gene expression in glioblastoma defined by ADC histogram analysis: relationship to extracellular matrix molecules and survival.
AJNR Am J Neuroradiol


Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas.
J Magn Reson Imaging



All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2017 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2017 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:12/14/2017 8:54:36 AM PST]